Eurofins Scientific SE revised earnings guidance for the fiscal year 2022. For the fiscal year 2022, the company now expects to report revenues of EUR 6,325 million, including EUR 400 million COVID revenues, compared with previous guidance of revenues of EUR 6,225 million, including EUR 300 million COVID revenues.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.72 EUR | +1.14% | -1.53% | -3.83% |
04-29 | CAC40: France's rating maintained = non-event | CF |
04-29 | CAC40: starts the week slightly up, crosses the 8100 mark | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.83% | 11.65B | |
+16.17% | 81.21B | |
-29.41% | 70.26B | |
+10.99% | 29.62B | |
-11.35% | 16.95B | |
+0.21% | 16.91B | |
-0.68% | 15.07B | |
-1.40% | 12.52B | |
+3.44% | 12.1B | |
+31.43% | 12B |
- Stock Market
- Equities
- ERF Stock
- News Eurofins Scientific SE
- Eurofins Scientific SE Revises Earnings Guidance for the Fiscal Year 2022